---
title: "SLRN.US (SLRN.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SLRN.US/news.md"
symbol: "SLRN.US"
name: "SLRN.US"
parent: "https://longbridge.com/zh-HK/quote/SLRN.US.md"
datetime: "2026-03-16T12:25:56.614Z"
locales:
  - [en](https://longbridge.com/en/quote/SLRN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLRN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLRN.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/SLRN.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/SLRN.US/news.md)


# SLRN.US (SLRN.US) — 相關新聞

### [Climb Bio Files Complaint Against Alumis And Acelyrin - SEC Filing](https://longbridge.com/zh-HK/news/271250597.md)
*2025-12-31T22:36:43.000Z*
### [Climb Bio Sues Alumis Over $3 Million Milestone Dispute](https://longbridge.com/zh-HK/news/271245218.md)
*2025-12-31T21:13:31.000Z*
### [ACELYRIN | 10-Q: FY2025 Q1 EPS Beats Estimate at USD -0.55](https://longbridge.com/zh-HK/news/240228818.md)
*2025-05-14T20:05:15.000Z*
### [ISS advises "FOR" ACELYRIN's merger with Alumis. ACELYRIN pushes stockholders to vote "FOR" deal today.](https://longbridge.com/zh-HK/news/238985754.md)
*2025-05-06T20:52:15.000Z*
> ACELYRIN is urging stockholders to vote "FOR" the proposed merger with Alumis today, emphasizing the significance of the